The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants

NCT00000961 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

112

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Anti-HIV Immune Serum Globulin (Human)
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]